Quarantine, isolation, and cohorting: From cholera to Klebsiella

Surgical Infections

Volumn 13, Issue 2, 2012, Pages 69-73

  Rosenberger, Laura H ^a   Riccio, Lin M ^a   Campbell, Kristin Turza ^a   Politano, Amani D ^a   Sawyer, Robert G ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; MUMPS VACCINE; PENICILLIN G; POLIOMYELITIS VACCINE; RUBELLA VACCINE; VACCINE; YELLOW FEVER VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; CHOLERA; COHORT ANALYSIS; DISEASE TRANSMISSION; HISTORY OF MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYGIENE; INFECTION CONTROL; KLEBSIELLA; KLEBSIELLA INFECTION; LEPROSY CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EPIDEMICS; HISTORY, 15TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, MEDIEVAL; HUMANS; PATIENT ISOLATION; QUARANTINE;

EID: 84859603326     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2011.067     Document Type: Review

References (51)

1. Leviticus 13:4-5. New International Version.
2. U.S. Centers for Disease Control and Prevention. Legal authorities for isolation and quarantine. Available at www.cdc .gov/quarantine/pdfs/legal- authorities-isolation-quarantine .pdf; last visited June 13, 2011.
3. Raoult D, Aboudharam G, Crubezy E, et al. Molecular identification by ''suicide PCR'' of Yersinia pestis as the agent of medieval Black Death. Proc Natl Acad Sci USA 2000;97: 12800-12803.
4. Pocket Oxford Italian Dictionary. 3rd edition. New York. Oxford University Press. 2006.
5. Markel H. Quarantine! East European Jewish Immigrants and the New York City Epidemics of 1892. Baltimore. Johns Hopkins University Press. 1997:3-4.
6. Valsecchi MC. Mass plague graves found on Venice ''quarantine'' island. National Geographic News, August 29, 2007. Available at http://news. nationalgeographic.com/news/2007/ 08/070829-venice-plague.html; last visited June 14, 2011.
7. Duffy J. A History of Public Health in New York City 1625- 1866. New York. Russell Sage Foundation. 1968:1-62.
8. Rosen G. Enlightenment and revolution. In: A History of Public Health. Baltimore. Johns Hopkins University Press. 1993:125-126.
9. Kass AM. Infectious diseases at the Boston city hospital: The first 60 years. Clin Infect Dis 1993;17:276-282.
10. Henderson DA. Vaccines and the eradication of smallpox. In: Mile Stones in Public Health: Accomplishments in Public Health over the Last 100 Years. New York. Pfizer Inc. 2006:5-11.
11. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35: S65-S164.
12. Curran J. Infectious disease control. In: Mile Stones in Public Health. Op. cit. [10]:73-75.
13. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996;17:53-80.
14. Frieden TR, Das-Douglas M, Kellerman SE, Henning KJ. Applying public health principles to the HIV epidemic. N Engl J Med 2005;353:2397-2402.
15. Klimek JJ, Marsik FJ, Bartlett RC, et al. Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. Am J Med 1976;61:340-345.
16. Jevons MP. ''Celbenin''-resistant staphylococci. Br Med J 1961;1:124-125.
17. Barber M. Methicillin-resistant staphylococci. J Clin Pathol 1961;14:385-393.
18. Knox R, Smith JT. Nature of penicillin resistance in staphylococci. Lancet 1961;2:520-522.
19. Barrett FF, McGehee RF, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital: Bacteriologic and epidemiologic observations. N Engl J Med 1968;279: 441-448.
20. Crossley K, Loesch D, Landesman B, et al. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides I: Clinical studies. J Infect Dis 1979;139:273-279.
21. Selkon JB, Stokes ER, Ingham HR. The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci. J Hosp Infect 1980;1:41-46.
22. Murray-Leisure KA, Geib S, Graceley D, et al. Control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11:343-350.
23. Guiguet M, Rekacewicz C, Leclercq B, et al. Effectiveness of simple measures to control an outbreak of nosocomial methicillin- resistant Staphylococcus aureus infections in an intensive care unit. Infect Control Hosp Epidemiol 1990;11:23-26.
24. Simor AE, Augustin A, Ng J, et al. Control of MRSA in a long-term care facility. Infect Control Hosp Epidemiol 1994;15:69-70.
25. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171: 614-624.
26. Gilroy SA, Stahl BM, Noonan C, et al. Reduction of hospitalacquired methicillin-resistant Staphylococcus aureus infection by cohorting patients in a dedicated unit. Infect Control Hosp Epidemiol 2009;30:203-205.
27. Heinrich N, Mueller A, Bartmann P, et al. Successful management of an MRSA outbreak in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 2011;30:909-913.
28. Knothe H, Shah P, Krcmery V, et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole, and cefuroxime in clinical isolates of Klebsiella pneumonia and Serratia marcescens. Infection 1983;11:315-317.
29. Bradford PA, Urban C, Mariano N, et al. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamse, and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997;41:563-569.
30. Macrae MB, Shannon KP, Rayner DM, et al. A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure. J Hosp Infect 2001;49:183-192.
31. Chan PC, Huang LM, Lin HC, et al. Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2007;28:423-429.
32. Laurent C, Rodriguez-Villalobos H, Rost F, et al. Intensive care unit outbreak of extended-spectrum b-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 2008;29:517-524.
33. Langer AJ, Lafaro P, Genese CA, et al. Using active microbiologic surveillance and enhanced infection control measures to control an outbreak of health care-associated extended-spectrum beta-lactamase-producing Klebsiella pneumonia infections-New Jersey, 2007. Am J Infect Control 2009;37:73-75.
34. Gregory CJ, Llata E, Stine N, et al. Outbreak of carbapenemresistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 2010;31:476-484.
35. MacKenzie FM, Forbes KJ. Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 1997;350:783.
36. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-161.
37. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycinresistant enterococci. Lancet 1988;1:57-58.
38. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195-200.
39. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-755.
40. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycinresistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995;21:45-50.
41. Jochimsen EM, Fish L, Manning K, et al. Control of vancomycin- resistant enterococci at a community hospital: Efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 1999;20:106-109.
42. Hanna H, Umphrey J, Tarrand J, et al. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 2001;22:217-219.
43. Sample ML, Gravel D, Oxley C, et al. An outbreak of vancomycin- resistant enterococci in a hematology-oncology unit: Control by patient cohorting and terminal cleaning of the environment. Infect Control Hosp Epidemiol 2002;23: 468-470.
44. Maragakis LL, Winkler A, Tucker MG, et al. Outbreak of multidrug-resistant Serratia marcescens infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2008;29:418-423.
45. Podnos YD, Cinat ME, Wilson SE, et al. Eradication of multidrug-resistant Acinetobacter from an intensive care unit. Surg Infect 2001;2:297-301.
46. Kohlenberg A, Brummer S, Higgins PG, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J Med Microbiol 2009;58:1499-1507.
47. McGrath EJ, Chopra T, Abdel-Haq N, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: Investigation and control. Infect Control Hosp Epidemiol 2011;32:34-41.
48. Zawacki A, O'Rourke E, Potter-Bynoe G, et al. An outbreak of Pseudomonas aeruginosa pneumonia and bloodstream infection associated with intermittent otitis externa in a healthcare worker. Infect Control Hosp Epidemiol 2004;25: 1083-1089.
49. Barie PS. Infection control is a matter of self control. Surg Infect 2001;2:253-254.
50. Rosenberger LH, Hranjec T, Politano AD, et al. Effective cohorting and ''superisolation'' in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms. Surg Infect (in press).
51. Huskins WC, Huckabee CM, O'Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011;364:1407-1418.